Differential Alterations of Dopamine Transporter in the Striatum and Midbrain in Patients With Parkinsonian Syndrome

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical Nuclear Medicine

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/RLU.0000000000000638PMID 25546191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques

  2013cited by this paper
• Assessing the Optimal Time Point for the Measurement of Extrastriatal Serotonin Transporter Binding with 123I-FP-CIT SPECT in Healthy, Male Subjects

  2012cited by this paper
• SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0*

  2012cited by this paper
• A novel computer-assisted image analysis of [123I]β-CIT SPECT images improves the diagnostic accuracy of parkinsonian disorders

  2011cited by this paper
• (18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism.

  2010cited by this paper
• Midbrain SERT in degenerative parkinsonisms: A 123I‐FP‐CIT SPECT study

  2010cited by this paper
• Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.

  2007influential reference
• Unique roles of SPET brain imaging in clinical and research studies. Lessons from Parkinson's disease research.

  2005cited by this paper
• The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

  1999cited by this paper
• The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.

  1999cited by this paper
• N‐substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter

  1997cited by this paper
• SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.

  1996cited by this paper
• N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

  1994cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper

• [18F]PR04.MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease

  2020cites this paper
• Constipation is not associated with dopamine transporter pathology in early drug‐naïve patients with Parkinson's disease

  2018cites this paper
• I‐123 DaTscan SPECT Brain Imaging in Parkinsonian Syndromes: Utility of the Putamen‐to‐Caudate Ratio

  2018cites this paper
• Generation of Integration-Free Induced Neurons Using Graphene Oxide-Polyethylenimine.

  2017cites this paper
• Is Occipital Cortex a Valid Reference Region in 123I-FP-CIT SPECT Imaging?

  2015cites this paper